Early anti-VEGF for diabetic retinopathy does not appear to benefit visual acuity

• Posted on: Mar 31 2023
• By: Saratoga Opthalmology
• Leave a response

For patients with nonproliferative diabetic retinopathy, treating early with aflibercept may slow disease progression, but it does not appear to positively impact vision long-term.
Source: AAO

Posted in: Uncategorized